{
    "abstract": "Although some women who undergo cesarean section need to receive prophylactic Enoxaparin due to the increased risk of thromboembolism during their puerperium period, the question is always raised of whether this drug with the mechanism of increased bleeding may increase surgical wound complications. Hence, the present study was conducted with the aim of a comparative study on complications of abdominal incision in cesarean section patients with and without receiving Enoxaparin.\nA quasi-experimental study was conducted on 789 cesarean section participants (317 receiving Enoxaparin and 472 control subjects), 20-40 years pregnant women in Imam Reza and Ummal-Banin hospitals in Mashhad, Iran. All participants who scored three or more for thromboembolism risk based on the National Protocol received Enoxaparin after surgery. Those with underlying wound complication risk factors were excluded from the study. Then, both groups were evaluated for abdominal incision complications up to 2 weeks after their delivery and were compared with each other. A \nIn total, 5% of patients in the Enoxaparin group and 5.5% in the control group had ulcer complications (\nBased on the outcomes obtained in the present study, prescribing Enoxaparin after a cesarean in cases receiving this drug for thromboembolic prophylaxis did not significantly increase the complications of abdominal incision, and there was no need for more incision care.",
    "authors": [
        {
            "affiliation": "Supporting the Family and the Youth of Population Research Core, Department of Obstetrics and Gynecology Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran.",
            "firstname": "Leili",
            "initials": "L",
            "lastname": "Hafizi"
        },
        {
            "affiliation": "Supporting the Family and the Youth of Population Research Core Hazrat Abolfazl Hospital, Mashhad University of Medical Sciences Kashmar Iran.",
            "firstname": "Freshteh",
            "initials": "F",
            "lastname": "Khoshniat"
        },
        {
            "affiliation": "Supporting the Family and the Youth of Population Research Core, Department of Obstetrics and Gynecology Faculty of Medicine, Mashhad University of Medical Sciences Mashhad Iran.",
            "firstname": "Masoumeh",
            "initials": "M",
            "lastname": "Mirteimouri"
        },
        {
            "affiliation": "Supporting the Family and the Youth of Population Research Core Mashhad University of Medical Sciences Mashhad Iran.",
            "firstname": "Safoura",
            "initials": "S",
            "lastname": "Khazaeian"
        }
    ],
    "conclusions": "Based on the outcomes obtained in the present study, prescribing Enoxaparin after a cesarean in cases receiving this drug for thromboembolic prophylaxis did not significantly increase the complications of abdominal incision, and there was no need for more incision care.",
    "copyrights": "\u00a9 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.",
    "doi": "10.1002/hsr2.70472",
    "journal": "Health science reports",
    "keywords": [
        "cesarean",
        "enoxaparin",
        "hematoma",
        "incision",
        "wound infection"
    ],
    "methods": null,
    "publication_date": "2025-02-18",
    "pubmed_id": "39963152\n34217368\n18510455\n18403925\n27262227\n26114874\n38287235\n38009657\n10841215\n11002955\n21173652\n15913620\n20472406\n20678746\n31246973\n16546357\n23958275\n26166335\n15746679\n22229365",
    "results": "In total, 5% of patients in the Enoxaparin group and 5.5% in the control group had ulcer complications (",
    "title": "Comparing Cesarean Incisional Complications in Women With and Without Enoxaparin: A Quasi-Experimental Study.",
    "xml": "<Element 'PubmedArticle' at 0x78850345ba10>"
}